Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Jul;24(3):396-400.
doi: 10.4103/0970-1591.42625.

Tuberculosis in renal transplant recipients

Madhivanan Sundaram, Samiran Das Adhikary, George T John, Nitin S Kekre

Tuberculosis in renal transplant recipients

Madhivanan Sundaram et al. Indian J Urol. 2008 Jul.

Abstract

Infective complications are common after renal transplantation. Tuberculosis (TB) is one of the leading infections following renal transplantation. Reactivation is the most common mode of infection. The factors responsible for this reactivation are chronic liver disease, other coexisting infections, particularly deep mycoses, pneumocystis pneumonia, nocardia, and CMV infections. Cyclosporine use advances the onset of TB to an earlier date. The median onset following transplantation is estimated to be 26 months for those who receive azathioprine and prednisolone as immunosuppression and 11 months for those who receive cyclosporine along with other immunosuppressive agents. Lung is the major site of involvement. Pyrexia of unknown origin is another common presentation. Culture and sensitivity has to be done in all possible cases. Amongst the serological techniques, Interferon alpha production is emerging as the most important. Rifampicin has to be avoided in allograft recipients as it activates cytochrome-P450 enzymes and thereby decreases the therapeutic levels of cyclosporine and prednisolone. The duration of treatment is usually extended for 18 months followed by secondary prophylaxis with isoniazid. Adverse effects of drugs are more often reported in organ recipients and have to be monitored for. Drug resistance is emerging as a problem and appropriate changes in the management have to be carried out.

Keywords: Organ transplantation; post transplant tuberculosis; tuberculosis; tuberculosis in solid organ transplantation.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

Figures

Figure 1
Figure 1
Location of post-transplant tuberculosis
See this image and copyright information in PMC

References

    1. RNCTB Annual Report, 2007. Status Reports 2007. Available from: http://www.tbcindia.org/pdfs/TB%20India%202007.pdf.
    1. John GT. Infections after renal transplantation in India. Indian J Nephrol. 2003;13:14.
    1. Sakhuja V, Jha V, Varma PP, Joshi K, Chugh KS. The high incidence of tuberculosis among renal transplant recipients in India. Transplantation. 1996;61:211. - PubMed
    1. Singh N, Paterson DL. Mycobacterium tuberculosis infection in solid organ transplantation recipients: Impact and implications for management. Clin Infect Dis. 1998;27:1266. - PubMed
    1. John GT, Date A, Mathew CM, Jeyaseelan L, Jacob CK, Shastry JC. A timetable of infections after transplantation in the tropics. Transplantation. 1996;61:970. - PubMed